
At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference. If this is your profile, we want to hear from you.
The Associate Director, Digital Medical Strategy is responsible for the execution and operationalization of digital initiatives that enable Medical Affairs, leveraging digital tools and platforms, AI, and integrated data and analytics. The role applies strong scientific and Medical Affairs strategic expertise to inform, evaluate, and contribute to current and emerging technologies that support Medical Affairs objectives.
Under the direction of the Executive Director, this position will contribute to and drive implementation of the Medical Affairs digital strategy and roadmap, building enterprise-wide foundational and long-term digital and AI capabilities. This role will collaborate with Global and Regional Medical Affairs colleagues and key cross-functional teams including enterprise-wide Medical Affairs, Global Digital Business Team, Clinical Development, Commercial, Legal, Regulatory, Compliance, and others to develop and drive the adoption and implementation of both internal and external facing digital initiatives. The Assoc Director, Digital Medical Strategy will also leverage digital tools and capabilities to enhance scientific content and digital scientific communication channels, including contributing to and supporting the strategic planning and execution of high-quality, compliant digital scientific communications across all digital medical channels.
#LI-MI1
The annual base salary range for the Associate Director, Digital Medical Strategy Oncology is from :$170,300-$223,500
Under current guidelines, this position is eligible to participate in : Eisai Inc. Annual Incentive Plan & Eisai Inc. Long Term Incentive Plan.
Final pay determinations will depend on various factors including but not limited to experience level, education, knowledge, and skills.
Employees are eligible to participate in Company employee benefit programs. For additional information on Company employee benefits programs, visit https://careers.eisai.com/us/en/compensation-and-benefits.
Certain other benefits may be available for this position, please discuss any questions with your recruiter.
Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status. Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans.
Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information:

At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US.
Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.